Mesenchymal Stem Cell-Derived Molecules Reverse Fulminant Hepatic Failure
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Modulation of the immune system may be a viable alternative in the treatment of fulminant hepatic failure (FHF) and can potentially eliminate the need for donor hepatocytes for cellular therapies. Multipotent bone marrow-derived mesenchymal stem cells (MSCs) have been shown to inhibit the function of various immune cells by undefined paracrine mediators in vitro. Yet, the therapeutic potential of MSC-derived molecules has not been tested in immunological conditions in vivo. Herein, we report that the administration of MSC-derived molecules in two clinically relevant forms-intravenous bolus of conditioned medium (MSC-CM) or extracorporeal perfusion with a bioreactor containing MSCs (MSC-EB)-can provide a significant survival benefit in rats undergoing FHF. We observed a cell mass-dependent reduction in mortality that was abolished at high cell numbers indicating a therapeutic window. Histopathological analysis of liver tissue after MSC-CM treatment showed dramatic reduction of panlobular leukocytic infiltrates, hepatocellular death and bile duct duplication. Furthermore, we demonstrate using computed tomography of adoptively transferred leukocytes that MSC-CM functionally diverts immune cells from the injured organ indicating that altered leukocyte migration by MSC-CM therapy may account for the absence of immune cells in liver tissue. Preliminary analysis of the MSC secretome using a protein array screen revealed a large fraction of chemotactic cytokines, or chemokines. When MSC-CM was fractionated based on heparin binding affinity, a known ligand for all chemokines, only the heparin-bound eluent reversed FHF indicating that the active components of MSC-CM reside in this fraction. These data provide the first experimental evidence of the medicinal use of MSC-derived molecules in the treatment of an inflammatory condition and support the role of chemokines and altered leukocyte migration as a novel therapeutic modality for FHF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511 · cited 1×
“In vitro studies have subsequently shown that MSCs actively inhibit the function of several immune cells through secreted cytokines, growth factors and enzymatic action, although controversy exists on the identity of the responsible mediators [7,8,9,10,11].”
BackgroundLe Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734
Gnecchi, M., He, H., Liang, O. D., Melo, L. G., Morello, F., Mu, H., Noiseux, N., Zhang, L., Pratt, R. E., Ingwall, J. S., et al. (2005) · Nature Medicine · doi:10.1038/nm0405-367 · Cited by 1,677 · cited 1×
“MSCs used for cellular cardiomyoplasty after an ischemic event revealed that MSC-derived soluble molecules inhibited hypoxia-induced apoptosis of cardiomyocytes during the acute phase of injury resolution [12,13].”
BackgroundMeisel, R., Zibert, A., Laryea, M., Göbel, U., Däubener, W., & Dilloo, D. (2004) · Blood · doi:10.1182/blood-2003-11-3909 · Cited by 1,646
Liechty, K. W., MacKenzie, T. C., Shaaban, A. F., Radu, A., Moseley, A. B., Deans, R., Marshak, D. R., & Flake, A. W. (2000) · Nature Medicine · doi:10.1038/81395 · Cited by 1,215
Gnecchi, M., He, H., Noiseux, N., Liang, O. D., Zhang, L., Morello, F., Mu, H., Melo, L. G., Pratt, R. E., Ingwall, J. S., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5211com · Cited by 1,157
Beyth, S., Borovsky, Z., Mevorach, D., Liebergall, M., Gazit, Z., Aslan, H., Galun, E., & Rachmilewitz, J. (2005) · Blood · doi:10.1182/blood-2004-07-2921 · Cited by 1,034
Maitra, B., Szekely, E., Gjini, K., Laughlin, M. J., Dennis, J., Haynesworth, S. E., & Koç, O. N. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704400 · Cited by 446
The role of mesenchymal stem cells in haemopoiesis
Dazzi, F., Ramasamy, R., Glennie, S., Jones, S. P., & Roberts, I. (2006) · Blood Reviews · doi:10.1016/j.blre.2005.11.002 · Cited by 361
A Bioartificial Liver--State of the Art
Strain, A. J., & Neuberger, J. M. (2002) · Science · doi:10.1126/science.1068660 · Cited by 284
Cited by
Mesenchymal stem cells in health and disease
Uccelli, A., Moretta, L., & Pistoia, V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2395 · Cited by 3,746
Mechanisms involved in the therapeutic properties of mesenchymal stem cells
da Silva Meirelles, L., Fontes, A. M., Covas, D. T., & Caplan, A. I. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.10.002 · Cited by 1,436
“found the presence of these and other anti-apoptotic molecules in MSC-conditioned medium and, interestingly, showed that an MSCcontaining bioreactor connected to the bloodstream of rats experimentally subjected to fulminant hepatic failure resulted in the survival of 71% of the animals in contrast to 14% survival in t…”
ResultMesenchymal stem cells: a new trend for cell therapy
Wei, X., Yang, X., Han, Z.-P., Qu, F.-F., Shao, L., & Shi, Y.-F. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.50 · Cited by 942
Strioga, M., Viswanathan, S., Darinskas, A., Slaby, O., & Michalek, J. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0722 · Cited by 825
Harnessing the Mesenchymal Stem Cell Secretome for the Treatment of Cardiovascular Disease
Ranganath, S. H., Levy, O., Inamdar, M. S., & Karp, J. M. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.02.005 · Cited by 809
Exosomes: Vehicles of Intercellular Signaling, Biomarkers, and Vectors of Cell Therapy
Kourembanas, S. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021014-071641 · Cited by 761
Mesenchymal Stem Cells as Therapeutics
Parekkadan, B., & Milwid, J. M. (2010) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-070909-105309 · Cited by 759
Self-citationLee, J. W., Fang, X., Gupta, N., Serikov, V., & Matthay, M. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907996106 · Cited by 715
Mesenchymal Stem Cells: Mechanisms of Immunomodulation and Homing
Yagi, H., Soto-Gutierrez, A., Parekkadan, B., Kitagawa, Y., Tompkins, R. G., Kobayashi, N., & Yarmush, M. L. (2010) · Cell Transplantation · doi:10.3727/096368910x508762 · Cited by 701
Self-citationDuijvestein, M., Vos, A. C. W., Roelofs, H., Wildenberg, M. E., Wendrich, B. B., Verspaget, H. W., Kooy-Winkelaar, E. M. C., Koning, F., Zwaginga, J. J., Fidder, H. H., et al. (2010) · Gut · doi:10.1136/gut.2010.215152 · Cited by 622
“Although the mechanisms underlying these effects are not fully elucidated, it has been shown that both cell–cell contact and the secretion of growth factors and cytokines are involved.”
BackgroundMesenchymal stem cells: a new strategy for immunosuppression and tissue repair
Shi, Y., Hu, G., Su, J., Li, W., Chen, Q., Shou, P., Xu, C., Chen, X., Huang, Y., Zhu, Z., et al. (2010) · Cell Research · doi:10.1038/cr.2010.44 · Cited by 575
Mesenchymal stromal cell secretome: influencing therapeutic potential by cellular pre-conditioning
Ferreira, J. R., Teixeira, G. Q., Santos, S. G., Barbosa, M. A., Almeida-Porada, G., & Gonçalves, R. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02837 · Cited by 572
Mesenchymal stem cell exosomes
Lai, R. C., Yeo, R. W. Y., & Lim, S. K. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.03.001 · Cited by 570
Stem Cells and Liver Regeneration
Duncan, A. W., Dorrell, C., & Grompe, M. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.05.044 · Cited by 548
Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy
Baglio, S. R., Pegtel, D. M., & Baldini, N. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00359 · Cited by 542
Regenerative Effects of Transplanted Mesenchymal Stem Cells in Fracture Healing
Granero-Moltó, F., Weis, J. A., Miga, M. I., Landis, B., Myers, T. J., O'Rear, L., Longobardi, L., Jansen, E. D., Mortlock, D. P., & Spagnoli, A. (2009) · Stem Cells · doi:10.1002/stem.103 · Cited by 530
Bone Marrow Stromal Cells Attenuate Lung Injury in a Murine Model of Neonatal Chronic Lung Disease
Aslam, M., Baveja, R., Liang, O. D., Fernandez-Gonzalez, A., Lee, C., Mitsialis, S. A., & Kourembanas, S. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200902-0242oc · Cited by 508
van Poll, D., Parekkadan, B., Cho, C. H., Berthiaume, F., Nahmias, Y., Tilles, A. W., & Yarmush, M. L. (2008) · Hepatology · doi:10.1002/hep.22236 · Cited by 501
Self-citationClinical applications of mesenchymal stem cells
Wang, S., Qu, X., & Zhao, R. C. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-19 · Cited by 483
Kuo, T. K., Hung, S., Chuang, C., Chen, C., Shih, Y. V., Fang, S. Y., Yang, V. W., & Lee, O. K. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.015 · Cited by 466
Prospect of Stem Cell Conditioned Medium in Regenerative Medicine
Pawitan, J. A. (2014) · BioMed Research International · doi:10.1155/2014/965849 · Cited by 463
Immunomodulation by Mesenchymal Stem Cells
Abdi, R., Fiorina, P., Adra, C. N., Atkinson, M., & Sayegh, M. H. (2008) · Diabetes · doi:10.2337/db08-0180 · Cited by 463
Pathogenesis of Acute Respiratory Distress Syndrome
Huppert, L., Matthay, M., & Ware, L. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1683996 · Cited by 459
Paracrine Mechanisms of Mesenchymal Stem Cells in Tissue Repair
Gnecchi, M., Danieli, P., Malpasso, G., & Ciuffreda, M. C. (2016) · Methods in Molecular Biology · doi:10.1007/978-1-4939-3584-0_7 · Cited by 449
Concise Review: Mesenchymal Stem Cells for Acute Lung Injury: Role of Paracrine Soluble Factors
Lee, J. W., Fang, X., Krasnodembskaya, A., Howard, J. P., & Matthay, M. A. (2011) · Stem Cells · doi:10.1002/stem.643 · Cited by 429
The therapeutic potential of mesenchymal stem cell‐derived extracellular vesicles
Katsuda, T., Kosaka, N., Takeshita, F., & Ochiya, T. (2013) · PROTEOMICS · doi:10.1002/pmic.201200373 · Cited by 423
Zhang, Z., Lin, H., Shi, M., Xu, R., Fu, J., Lv, J., Chen, L., Lv, S., Li, Y., Yu, S., et al. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.07024.x · Cited by 372
Organ Preservation: Current Concepts and New Strategies for the Next Decade
Guibert, E. E., Petrenko, A. Y., Balaban, C. L., Somov, A. Y., Rodriguez, J. V., & Fuller, B. J. (2011) · Transfusion Medicine and Hemotherapy · doi:10.1159/000327033 · Cited by 354
Golpanian, S., Wolf, A., Hatzistergos, K. E., & Hare, J. M. (2016) · Physiological Reviews · doi:10.1152/physrev.00019.2015 · Cited by 343
Ionescu, L., Byrne, R. N., van Haaften, T., Vadivel, A., Alphonse, R. S., Rey-Parra, G. J., Weissmann, G., Hall, A., Eaton, F., & Thébaud, B. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00144.2011 · Cited by 323
Human liver stem cell‐derived microvesicles accelerate hepatic regeneration in hepatectomized rats
Herrera, M. B., Fonsato, V., Gatti, S., Deregibus, M. C., Sordi, A., Cantarella, D., Calogero, R., Bussolati, B., Tetta, C., & Camussi, G. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00860.x · Cited by 307
Banas, A., Teratani, T., Yamamoto, Y., Tokuhara, M., Takeshita, F., Osaki, M., Kawamata, M., Kato, T., Okochi, H., & Ochiya, T. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0034 · Cited by 306
Mesenchymal Stromal Cells: A Novel Treatment Modality for Tissue Repair
Bernardo, M. E., Locatelli, F., & Fibbe, W. E. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04607.x · Cited by 295
Anti-inflammatory effects of mesenchymal stem cells: novel concept for future therapies
Iyer, S. S., & Rojas, M. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.5.569 · Cited by 269
Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells
Chiesa, S., Morbelli, S., Morando, S., Massollo, M., Marini, C., Bertoni, A., Frassoni, F., Bartolomé, S. T., Sambuceti, G., Traggiai, E., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103650108 · Cited by 269
Mesenchymal stem cell therapy for liver fibrosis
Eom, Y. W., Shim, K. Y., & Baik, S. K. (2015) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2015.30.5.580 · Cited by 226
“Moreover, IDO and HLA-G suppress the proliferation of effector T cells, inhibit the maturation of DCs, inhibit the proliferation and immunoglobulin G secretion of B cells and reduce the cytotoxicity of NK cells [36,37].”
BackgroundEl-Ansary, M., Abdel-Aziz, I., Mogawer, S., Abdel-Hamid, S., Hammam, O., Teaema, S., & Wahdan, M. (2012) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9322-y · Cited by 179
Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice
Meier, R. P. H., Mahou, R., Morel, P., Meyer, J., Montanari, E., Muller, Y. D., Christofilopoulos, P., Wandrey, C., Gonelle-Gispert, C., & Bühler, L. H. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.030 · Cited by 153
The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases
Liu, W., Song, F., Ren, L., Guo, W., Wang, T., Feng, Y., Tang, L., & Li, K. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12482 · Cited by 139
Mesenchymal stromal cells in hepatic fibrosis/cirrhosis: from pathogenesis to treatment
Yang, X., Li, Q., Liu, W., Zong, C., Wei, L., Shi, Y., & Han, Z. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-00983-5 · Cited by 120
Fouraschen, S. M. G., Pan, Q., de Ruiter, P. E., Farid, W. R. R., Kazemier, G., Kwekkeboom, J., Ijzermans, J. N. M., Metselaar, H. J., Tilanus, H. W., de Jonge, J., et al. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0560 · Cited by 102
“Research by van Poll and colleagues shows a stimulating effect of bone marrow-derived MSC (BM-MSC)secreted factors on liver regeneration in the setting of toxic liver injury and hepatic failure [24,25].”
Mesenchymal stem cell therapy for liver fibrosis/cirrhosis
Cao, Y., Ji, C., & Lu, L. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.119 · Cited by 99
“MSC-CM could also increase the secretion of anti-inflammatory IL-10 and improve survival rate of rats with D-galactosamine-induced liver failure (28).”
BackgroundAraújo, A. B., Salton, G. D., Furlan, J. M., Schneider, N., Angeli, M. H., Laureano, Á. M., Silla, L., Passos, E. P., & Paz, A. H. (2017) · Cytotherapy · doi:10.1016/j.jcyt.2017.03.001 · Cited by 83
(2013) · Europe PMC (PubMed Central) · Cited by 75
RetractedMesenchymal stromal cells: promising treatment for liver cirrhosis
Yao, L., Hu, X., Dai, K., Yuan, M., Liu, P., Zhang, Q., & Jiang, Y. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03001-z · Cited by 71
Shen, K., Chang, W., Gao, X., Wang, H., Niu, W., Song, L., & Qin, X. (2011) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmr005 · Cited by 57
Zagoura, D., Trohatou, O., Makridakis, M., Kollia, A., Kokla, N., Mokou, M., Psaraki, A., Eliopoulos, A. G., Vlahou, A., & Roubelakis, M. G. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.07.009 · Cited by 39
“MSCs produce IL-10 [49], IL-1 receptor antagonist (IL-1ra) [50], Hepatocyte Growth Factor (HGF) [51], VEGF and Insulin-like growth factorbinding protein (IGFBP) [52]which dampen inflammation and promote liver recovery [53–55].”
BackgroundMesenchymal stem cell therapy as a game-changer in liver diseases: review of current clinical trials
Huang, W.-C., Li, Y.-C., Chen, P.-X., Ma, K. S.-K., & Wang, L.-T. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-04127-y · Cited by 29
Sang, W., Lv, B., Li, K., & Lu, Y. (2018) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2017.11.003 · Cited by 20
Chen, B., Pang, L., Cao, H., Wu, D., Wang, Y., Tao, Y., Wang, M., & Chen, E. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001455 · Cited by 14
Elberry, D. A., Amin, S. N., Esmail, R. S. E. N., Rashed, L. A., & Gamal, M. M. (2016) · IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund · doi:10.17179/excli2016-645 · Cited by 12
Metadata
- Authors
- Parekkadan, B., van Poll, D., Suganuma, K., Carter, E. A., Berthiaume, F., Tilles, A. W., & Yarmush, M. L.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-09-26
- Volume
- 2
- Issue
- 9
- Pages
- e941
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2165073735
- Cited by
- 510
- References
- 14
- FWCI
- 10.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.